BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25639748)

  • 1. The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry.
    Vissers PA; Mols F; Thong MS; Pouwer F; Vreugdenhil G; van de Poll-Franse LV
    J Cancer Surviv; 2015 Sep; 9(3):523-31. PubMed ID: 25639748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
    Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
    J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry.
    Ezendam NP; Pijlman B; Bhugwandass C; Pruijt JF; Mols F; Vos MC; Pijnenborg JM; van de Poll-Franse LV
    Gynecol Oncol; 2014 Dec; 135(3):510-7. PubMed ID: 25281491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study.
    van Erning FN; Janssen-Heijnen MLG; Wegdam JA; Slooter GD; Wijsman JH; Vreugenhil A; Beijers TAJM; van de Poll-Franse LV; Lemmens VEPP
    Clin Colorectal Cancer; 2017 Sep; 16(3):195-203. PubMed ID: 27756521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.
    Mols F; Beijers AJ; Vreugdenhil G; Verhulst A; Schep G; Husson O
    J Cancer Surviv; 2015 Sep; 9(3):512-22. PubMed ID: 25876556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
    Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life.
    Stefansson M; Nygren P
    Acta Oncol; 2016; 55(9-10):1227-1235. PubMed ID: 27550718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors.
    Teng C; ; Blinman PL; Vardy JL
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1308-1315. PubMed ID: 36509075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Neuropathy: Comparison of Symptoms and Severity Between Colorectal Cancer Survivors and Patients With Diabetes.
    Wu CJ; Huang KJ; Tsai YC; Yeh TP; Hsieh CF; Wang YJ
    Clin J Oncol Nurs; 2021 Aug; 25(4):395-403. PubMed ID: 34269355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
    Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
    Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of participation restrictions on everyday life in long-term colorectal cancer survivors in the EnCoRe study: A mixed-method study.
    Breedveld-Peters JJL; Bours MJL; Cords CI; Ditters IAM; Habraken V; Jongen MWJ; Weijenberg MP
    Eur J Oncol Nurs; 2020 Apr; 45():101724. PubMed ID: 32044722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry.
    Bonhof CS; van de Poll-Franse LV; Vissers PAJ; Wasowicz DK; Wegdam JA; Révész D; Vreugdenhil G; Mols F
    Psychooncology; 2019 Sep; 28(9):1926-1933. PubMed ID: 31293046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
    Tofthagen C; McAllister RD; McMillan SC
    Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term peripheral neuropathy symptoms in breast cancer survivors.
    Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
    Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry.
    Bours MJ; Beijer S; Winkels RM; van Duijnhoven FJ; Mols F; Breedveld-Peters JJ; Kampman E; Weijenberg MP; van de Poll-Franse LV
    Br J Nutr; 2015 Jul; 114(2):286-96. PubMed ID: 26079602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
    Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
    Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.
    Wolf SL; Barton DL; Qin R; Wos EJ; Sloan JA; Liu H; Aaronson NK; Satele DV; Mattar BI; Green NB; Loprinzi CL
    Support Care Cancer; 2012 Mar; 20(3):625-32. PubMed ID: 21479990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors.
    Calcaterra SL; Burnett-Hartman AN; Powers JD; Corley DA; McMullen CM; Pawloski PA; Feigelson HS
    BMC Cancer; 2020 May; 20(1):373. PubMed ID: 32362277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: results from the population-based PROFILES registry.
    Verhaar S; Vissers PA; Maas H; van de Poll-Franse LV; van Erning FN; Mols F
    Eur J Cancer; 2015 Jul; 51(10):1263-73. PubMed ID: 25953068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.